Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 4313 - 4320 of 11613 results
It’s Time to Prepare for the FY2021 H-1B Visa Filing Season
December 4, 2019| Alert| Viewpoint
Mintz Member Matthew Simpson Featured in The Deal’s PE Movers & Shakers Column
December 4, 2019| News
SEC Provides Guidance and Proposes Amendments to Shareholder Proposal Rules
December 3, 2019| Alert| Viewpoint
Legal Implications of Using AI, Biometrics, or Bots in the Workplace
December 3, 2019| News
Key Vote in FDA Commissioner Confirmation Process Set for December 3rd
December 2, 2019| Blog| Viewpoint
Law360, MassLive Cover Mintz, ACLU’s Groundbreaking Victory for Immigrants’ Rights
December 2, 2019| News
Revised Guidelines on the Territorial Scope of the GDPR and Local Representatives
December 2, 2019| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.